Endocrinology
Branch of medicine dealing the endocrine system
Follow Endocrinology on Notably News to receive short updates to your email — rarely!
We include updates on Pheromone, Corticosteroid, Menopause, Tanner scale, Hormone, Late-onset hypogonadism, Glycemic index, Iodised salt, Renin–angiotensin system, Endocrine disruptor, Metabolic disorder, Octreotide, Thelarche, Breast development, Triiodothyronine, Endocrine disease ... and more.
| 2023 |
Metabolic disorder
A meta-analysis of six cohort studies involving 484,994 participants was conducted, examining the relationship between metabolic syndrome and Alzheimer's disease risk, finding no significant overall association but identifying links between individual metabolic components and increased AD risk.
|
| 2023 |
Metabolic disorder
A systematic review and meta-analysis demonstrated the effectiveness of medical nutrition therapy (MNT) in managing metabolic disorders, showing significant improvements in glycemic control, anthropometric measures, lipid profiles, and blood pressure for adults with prediabetes when nutrition interventions are personalized.
|
| 2022 | USPSTF again evaluated and maintained the 'D' score recommendation against hormone replacement therapy for chronic postmenopausal symptoms. |
| 2022 | USPSTF again evaluated HRT and maintained their 'D' score recommendation against using hormone replacement therapy for chronic disease prevention in postmenopausal women. |
| July 28 2020 | Most recent study update published in JAMA, reporting persistent increased breast cancer risk among women randomized to estrogen plus progestin compared with placebo, with a hazard ratio of 1.28. |
| July 28 2020 | JAMA publication reporting persistent increased breast cancer risk for women randomized to estrogen plus progestin compared to placebo, with a hazard ratio of 1.28 and statistically significant p-value. |
| 2017 | Published a cumulative 18-year follow-up analysis of 27,347 postmenopausal women, examining the long-term impacts of hormone therapy trials, finding no significant association with all-cause, cardiovascular, or total cancer mortality. |
| 2017 | The United States Preventive Services Task Force (USPSTF) published a recommendation discouraging hormone replacement therapy for preventing chronic diseases in postmenopausal women, downgrading their previous recommendation from a 'B' to a 'D' grade. |
| April 2016 | Received the 2016 Team Science Award from the American Association for Cancer Research (AACR), honoring over 20 years of work that 'singularly changed the face of women's medicine around the world'. |
| 2015 | WHI initiates Extension Study 3, with preliminary estimates showing 81,386 active participants (36,115 from Clinical Trials and 45,271 from Observational Study), representing 87% of those enrolled in Extension Study 2. |
| 2015 | Launched the Women's Health Initiative Strong and Healthy Study (WHISH), a four-year research project examining the impact of physical activity on older women's health outcomes, including heart disease and independent lifestyle maintenance. The study enrolled nearly 50,000 participants with varied physical activity interventions monitored through mail and phone using an interactive voice response (IVR) system. |
| 2015 | The Women's Health Initiative (WHI) study was awarded the Team Science Award from the Association for Clinical and Translational Science (ACTS), recognizing the team's success in translating research discoveries into clinical applications and widespread clinical practice. |
| 2013 | An analysis of extramural clinical trials revealed the Women's Health Initiative (WHI) study components were among the most frequently cited in medical literature. The Estrogen plus Progestin (E+P) trial ranked first among all National Heart, Lung, and Blood Institute (NHLBI)-sponsored clinical trials, averaging 812.5 citations annually. |
| 2013 | A subset of approximately 7,400 LLS participants were enrolled in the Objective Physical Activity and Cardiovascular Health in Women (OPACH) study to assess physical activity, sleep patterns, and falls among women capable of ambulation. |
| May 2013 | The Long Life Study (LLS) completed its in-person visits and blood collections for a subsample of 7,875 Women's Health Initiative participants aged 63-99, establishing new baselines for studies in disease and aging. |
| 2010 | WHI launches Extension Study 2, enrolling 93,540 participants (87% of those from Extension Study 1), continuing the longitudinal research on women's health. |
This contents of the box above is based on material from the Wikipedia articles Metabolic disorder & Women's Health Initiative, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.